OneMedNet reduces liabilities by 75% while expanding healthcare network

OneMedNet Corporation (NASDAQ: ONMD) reported a 75% reduction in total liabilities, cutting approximately $19.6 million by the end of 2025 compared to December 31, 2024, according to a shareholder letter from CEO Aaron Green.

The Minneapolis-based company expanded its healthcare provider network by 37% year-over-year, reaching 186 million clinical exams across more than 2,130 healthcare partner sites. OneMedNet provides real-world data services to life sciences organizations.

The company selected Palantir Technologies' (NASDAQ: PLTR) AI platform in October 2025 to accelerate platform development. OneMedNet plans to launch an AI-driven multimodal subscription search service in 2026.

Third-quarter bookings increased eight-fold year-over-year from 2024 to 2025, according to the letter. The company hired additional sales leadership and expanded its commercial team during 2025.

OneMedNet's indexed Real-World Data platform integrates medical imaging, lab results, clinical notes and electronic health records. The company provides de-identified data from hospitals and clinics for drug development and regulatory submissions.

For 2026, OneMedNet plans to introduce additional platform services including tools for hospitals and clinics to analyze their own data. The company also intends to expand into Health Economics and Outcomes Research solutions.

The real-world data market serves pharmaceutical companies, medical device manufacturers and AI developers. OneMedNet cited an estimated $868 billion AI-driven healthcare market opportunity by 2030, referencing Strategy& PWC research.

Green noted growing regulatory acceptance of real-world evidence by the FDA and European Medicines Agency for drug approval and post-market surveillance processes.

You May Also Be Interested In